Abbott gets USFDA emergency use authorization for COVID-19 molecular test Medical Dialogues Bureau20 March 2020 4:45 AM GMTThe Abbott m2000 RealTime System is a molecular solution featuring a broad menu of tests, including ones for infectious diseases.